As one of the leading manufacturers of medical laboratory diagnostics worldwide, EUROIMMUN stands for innovation.

More than 3100 employees in 17 countries develop, produce and sell test systems to support the diagnosis of diseases, as well as software and automation solutions for optimized performance and evaluation of these tests. Laboratories in over 150 countries use EUROIMMUN products to aid in the diagnosis of autoimmune and infectious diseases as well as allergies, and to perform genetic analyses.

The company was founded in 1987 from the University of Lübeck (Schleswig-Holstein, Germany) by Prof. Dr. Winfried Stöcker. Since 2018, the US-based PerkinElmer, Inc. is the sole shareholder of EUROIMMUN. PerkinElmer is an international leader in medical and biotechnology. The company, which has its headquarters in Waltham (Massachusetts), has 13,000 employees worldwide. With its innovative test systems, imaging and IT systems, it offers an extensive expertise in diagnostics, medical research and environmental and food analysis. PerkinElmer, Inc. is listed on the S&P-500 Index.

Among the initial pioneering achievements of EUROIMMUN was the development of BIOCHIPs in 1983. Today, the company uses fully-automated BIOCHIP fragmentation and production machines which are designed and produced in-house and are in use world-wide.
Furthermore, the company commands a broad technology base, which it has drawn on to stimulate and promote fundamental new developments in medical laboratory diagnostics. Examples are the molecular biological synthesis of designer antigens, the computer-based immunofluorescence microscopy (CAIFM) and the development of multi-parameter microarrays for the identification of gene polymorphisms and pathogens.